Skip to content

The Effect of Uni-Hemispheric Dual-Site Anodal tDCS on post-stroke cognitive impairment and its brain mechanism

The Effect of Uni-Hemispheric Dual-Site Anodal tDCS on post-stroke cognitive impairment and its brain mechanism

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096896
Enrollment
Unknown
Registered
2025-02-08
Start date
2024-06-03
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Intervention group:That is, true-angular gyration anode stimulation + DLPFC stimulation Using machines with two tDCS, place the anode electrode of one tDCS in the dorsolateral prefrontal lobe of the b
Control group:i.e., false-angular gyration anodic stimulation + DLPFC stimulation The placement and treatment parameters were the same as those of the observation group. The device of the stimulation

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meets diagnostic criteria for post-stroke cognitive impairment; (2) First onset, course of disease >=1 month, stable condition; (3) Age >=18 years old and <=80 years old, both sexes, right-handed; (4) Montreal Cognitive Assessment (MoCA) score <26; (5) No aphasia, native speaker of Chinese, can cooperate to complete the test; (6) Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Progression of cerebrovascular disease; (2) Severe heart, liver, or kidney diseases that make the patient unable to tolerate the trial; (3) History of epilepsy or a family history of epilepsy, recent use of epileptogenic drugs; (4) Skull fractures and/or severe head injuries; history of head and/or brain surgery; (5) History of smoking, alcoholism, or pregnancy.

Design outcomes

Primary

MeasureTime frame
Change in Montreal Cognitive Assessment (MoCA) score at the end of 10 treatments;

Secondary

MeasureTime frame
Digit Span;Trail making test;near-infrared spectroscopy ;The patient's own condition;

Countries

China

Contacts

Public ContactXiayan Xue

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

yan_xue_0710@163.com+86 139 1898 5486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026